1. Home
  2. CCCC vs EPSN Comparison

CCCC vs EPSN Comparison

Compare CCCC & EPSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.91

Market Cap

185.1M

Sector

Health Care

ML Signal

HOLD

Logo Epsilon Energy Ltd.

EPSN

Epsilon Energy Ltd.

HOLD

Current Price

$5.77

Market Cap

192.3M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCCC
EPSN
Founded
2015
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
185.1M
192.3M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
CCCC
EPSN
Price
$2.91
$5.77
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$12.20
N/A
AVG Volume (30 Days)
2.4M
246.2K
Earning Date
05-06-2026
05-13-2026
Dividend Yield
N/A
4.17%
EPS Growth
16.45
N/A
EPS
N/A
N/A
Revenue
$35,947,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.02
N/A
52 Week Low
$1.20
$4.20
52 Week High
$3.82
$8.50

Technical Indicators

Market Signals
Indicator
CCCC
EPSN
Relative Strength Index (RSI) 55.72 43.67
Support Level $2.30 $4.43
Resistance Level $3.82 $5.98
Average True Range (ATR) 0.23 0.24
MACD 0.01 -0.09
Stochastic Oscillator 82.64 32.14

Price Performance

Historical Comparison
CCCC
EPSN

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

About EPSN Epsilon Energy Ltd.

Epsilon Energy Ltd is engaged in the acquisition, development, gathering, and production of natural gas and oil reserves. The operating segments of the company include Upstream segment activities including acquisition, development, and production of natural gas reserves on properties within the United States. The Gas Gathering segment partners with two other companies to operate a natural gas gathering system, and the corporate segment activities include corporate listing and governance functions of the corporation. The company generates revenue from the sale of crude oil and natural gas.

Share on Social Networks: